TECTONIC THERAPEUTIC, INC. Gain (Loss) on Disposition of Other Assets
TECTONIC THERAPEUTIC, INC. (TECX) reported Gain (Loss) on Disposition of Other Assets of $3.76 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfOtherAssets · last filed 2024-05-09
- TECTONIC THERAPEUTIC, INC. gain (loss) on disposition of other assets for the quarter ending 2024-03-31 was $3.76M.
- TECTONIC THERAPEUTIC, INC. gain (loss) on disposition of other assets for the quarter ending 2023-12-31 was $79.97M.
- TECTONIC THERAPEUTIC, INC. gain (loss) on disposition of other assets for the quarter ending 2023-09-30 was $83.74M.
- TECTONIC THERAPEUTIC, INC. gain (loss) on disposition of other assets for the quarter ending 2023-06-30 was $83.74M.
| Period end | Gain (Loss) on Disposition of Other Assets | Gain (Loss) on Disposition of Other Assets 3 month | Gain (Loss) on Disposition of Other Assets 6 month | Gain (Loss) on Disposition of Other Assets 9 month | Gain (Loss) on Disposition of Other Assets 12 month | Gain (Loss) on Disposition of Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-03-31 | $3.76M 10-Q · filed 2024-05-09 | $83.74M derived: sum of 2 quarters · filed 2024-05-09 | $167.47M derived: sum of 3 quarters · filed 2024-05-09 | $251.21M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2023-12-31 | $79.97M derived: 10-Q 12 month − 10-Q 9 month · filed 2024-05-09 | $163.71M derived: sum of 2 quarters · filed 2024-05-09 | $247.44M derived: sum of 3 quarters · filed 2024-05-09 | $83.74M 10-Q · filed 2024-05-09 | $3.76M 10-K · filed 2024-03-14 | |
| 2023-09-30 | $83.74M 10-Q · filed 2023-11-09 | $167.47M derived: sum of 2 quarters · filed 2023-11-09 | $3.76M 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | $83.74M 10-Q · filed 2023-08-10 | $3.76M 10-Q · filed 2023-08-10 | ||||
| 2023-06-09 | $83.74M 10-Q · filed 2024-05-09 | |||||
| 2023-05-19 | $83.74M 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |